Digital Intervention to Support Mental Health in Transgender and Gender-Diverse Young Adults and Their Caregivers
Led by Boston Children's Hospital · Updated on 2026-09-09
500
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating an interactive educational app designed to support transgender and gender-diverse TGD young adults aged 18 to 29 years and their caregivers. This randomized controlled trial aims to assess how access to this app affects mental health outcomes such as suicidal ideation, psychological distress, and anxiety. The study also examines changes in caregiver support and communication, with a focus on diverse racial and ethnic groups to ensure the intervention works well for all participants.
Participants are randomly assigned to either an Immediate Arm, which provides access to the digital platform plus usual care right after enrollment, or a Deferred Arm, which offers usual care alone and access to the app after six months. Usual care includes access to published resources and community support organizations, including suicide prevention hotline information. The intervention lasts for six months for each arm, followed by six months of observation where access to the app continues.
Participants will be assessed at baseline, and then at 3, 6, and 12 months to measure changes in mental health using tools like the Columbia Suicide Severity Rating Scale and Patient Health Questionnaire-9. The study includes surveys and data collected through the app, along with focus groups and interviews to improve the interventions effectiveness. The total participation spans one year, during which mental health outcomes and caregiver support are closely monitored and analyzed.
CONDITIONS
Brief Title
THE GUIDE: Transforming Health for Young Adults Using Interventions to Drive Engagement
Research Team
C
Cassandra Program Manager
C
Cassandra Morrow
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Interactive digital platform
Waitlist control with usual care
Current affirming care
What the option is
Mobile‑ and web‑based personalized educational modules and interactive features supporting mental health and communication for TGD young adults and caregivers
Waitlist control allowing usual care resources such as published guidance and suicide prevention hotlines, with platform access delayed by 6 months
Standards of care include multidisciplinary affirming mental health and preventive screening practices
Role in the trial
Investigational intervention received immediately by participants in active arm
Comparator arm receiving usual care with delayed access to the platform after six months
Reflects existing affirming mental health approaches not randomized in the trial
Primary use
To improve knowledge, mental health self‑management, and family communication for TGD young adults
To serve as a control while providing usual care and delayed platform exposure
Includes preventive screening and psychosocial support recommended by current guidelines
How it is given or performed
Participants and caregivers access self‑paced digital modules and interactive features online
Participants receive usual care and access platform after six months
Provided through affirming clinical and family‑supportive practices as part of routine mental health care
Evidence status
Effectiveness under evaluation; outcomes measured include suicidal ideation and depression over 12 months
Control arm for trial comparison; effect measured against immediate platform access
Multidisciplinary affirming support is core element of WPATH standards of care
Important risks
Potential privacy or engagement challenges, but specific safety profile not yet established
Low risk usual care resources; no direct intervention risks
Affirming mental health care generally considered low risk when delivered by qualified providers
Important limitations
Effectiveness for long‑term mental health and generalizability to all TGD subpopulations unknown
Delayed access may reduce equity in timely support for at‑risk individuals
Access to affirming care varies by region and provider availability
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years - 29Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Gender diverse individuals aged 18-29 years residing in California, Oregon, Illinois, Maryland, District of Columbia, Vermont, Connecticut, Massachusetts, Michigan, New Jersey, or New York
Caregivers of gender diverse individuals aged 18-29 years residing in California, Oregon, Illinois, Maryland, District of Columbia, Vermont, Connecticut, Massachusetts, Michigan, New Jersey, or New York
You will not qualify if you...
Inability to speak, read, and write English
Lack of device with Internet access
Current residence outside California, Oregon, Illinois, Maryland, District of Columbia, Vermont, Connecticut, Massachusetts, Michigan, New Jersey, or New York
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Intervention and Observation
Duration - 12 months
Participants are assigned to either immediate access to the educational app plus usual care, or usual care with delayed app access after six months. The intervention period lasts six months, followed by six months of observation where app access continues.
Assessments at baseline, 3, 6, and 12 months
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Studying Early Brain Effects of Testosterone Hormone Therapy in Adult Transgender Men Compared to Placebo
Study on Immune Responses to Meningococcal B Vaccine in Healthy Adults Aged 18 to 50
Including Transgender and Cisgender Men and Women
Study on Changes in Pain Sensitivity During Gender Affirming Hormone Therapy for Transgender Adults
Impact of Testosterone Hormone Therapy on Headache and Brain Structure in Transmasculine Adolescents and Young Adults
Research Participation With Transgender and Gender-Diverse Youth
Study on How Hormones Affect Pain Sensitivity in Cisgender and Transgender Adults Aged 18 to 65
The Copenhagen Gender Identity Cohort Study on Medical and Surgical Treatments for Gender Incongruence in Adults
Digital Intervention to Support Mental Health in Transgender and Gender-Diverse Young Adults and Their Caregivers
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Transforming Mental Health for Transgender and Gender-Diverse Young Adults Using Interventions to Drive Equity (TransHealthGUIDE): Protocol for a Digital Randomized Controlled Trial.
Sari L Reisner, S Wilson Cole, Alex S Keuroghlian...